Department of Cardiology, Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200030, China.
Eur Heart J. 2010 Nov;31(21):2633-41. doi: 10.1093/eurheartj/ehq201. Epub 2010 Jun 23.
Catheter ablation and surgical Maze procedure are effective in treating atrial fibrillation (AF) patients. However, there is no study that compares the effect of circumferential pulmonary vein isolation (CPVI) combined with substrate ablation after valvular surgery and the concomitant Maze procedure for the treatment of AF in patients with rheumatic heart disease (RHD). The aim of this study was to compare the effectiveness of CPVI combined with substrate modification and surgical Maze procedure using Saline-Irrigated Cooled-tip Radiofrequency Ablation (SICTRA) system for the treatment of long-lasting persistent AF in patients with RHD.
Between January 2006 and June 2008, 99 patients with long-lasting persistent AF and RHD were randomly assigned to undergo valvular operation and CPVI combined with substrate modification 6 months after the surgery (Group A, 49 patients) or valvualr operation and concomitant Maze procedure (Group B, 50 patients). The mean follow-up periods were 15 ± 5 and 20 ± 8 months in Groups A and B, respectively. After one procedure, Group B had a significantly higher freedom from artial arrhythmias compared with Group A (82% in Group B vs. 55.2% in Group A, P < 0.001). Fifteen patients in Group A underwent a redo procedure. Six patients in Group B underwent catheter ablation and four were treated successfully. The cumulative rates of sinus rhythm were 71% in Group A and 88% in Group B (P < 0.001).
The concomitant Cox Maze procedure using SICTRA is more effective than subsequent CPVI combined with substrate modification in treating patients with long-lasting persistent AF and RHD.
导管消融和外科迷宫手术在治疗心房颤动(AF)患者方面是有效的。然而,目前还没有研究比较瓣膜手术后行环形肺静脉电隔离(CPVI)联合基质消融与同期迷宫手术治疗风湿性心脏病(RHD)患者 AF 的效果。本研究旨在比较 CPVI 联合基质改良和使用盐水灌流冷尖端射频消融(SICTRA)系统的外科迷宫手术治疗 RHD 患者持续性长程 AF 的有效性。
2006 年 1 月至 2008 年 6 月,99 例持续性长程 AF 和 RHD 患者随机分为瓣膜手术后 6 个月行瓣膜手术和 CPVI 联合基质改良(A 组,49 例)或瓣膜手术和同期迷宫手术(B 组,50 例)。A 组和 B 组的平均随访时间分别为 15 ± 5 个月和 20 ± 8 个月。一次手术后,B 组的无房性心律失常的比例明显高于 A 组(B 组 82%,A 组 55.2%,P < 0.001)。A 组中有 15 例患者行二次手术。B 组中有 6 例患者行导管消融,4 例成功。A 组窦性心律的累积率为 71%,B 组为 88%(P < 0.001)。
使用 SICTRA 的同期 Cox 迷宫手术比后续 CPVI 联合基质改良治疗持续性长程 AF 和 RHD 患者更有效。